Study Summary
The researchers are doing this study to look at how butyrate levels change in participants' stool after they are on a- plant-based diet for at least 12 weeks. All participants will have monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM). We will compare how the plant-based diet, omega-3 fatty acid and curcumin supplements, and placebo (an inactive substance that looks like the study supplements) affect butyrate levels in participants' stool.
- Monoclonal Gammopathy of Undetermined Significance
- Multiple Myeloma
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 12 weeks
Trial Safety
Safety Progress
Trial Design
3 Treatment Groups
Whole Foods Plant-based Diet
1 of 3
Supplements
1 of 3
Placebo
1 of 3
Experimental Treatment
Non-Treatment Group
150 Total Participants · 3 Treatment Groups
Primary Treatment: Whole Foods Plant-based Diet · Has Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| New York | 100.0% |
What site did they apply to?
| Memorial Sloan Kettering Westchester (All Protocol Activities) | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |